Women's Health

Co-creating digital solutions to support cervical cancer screening

co-creating digital solutions_thumbnail

The World Health Organisation strongly encourages the use of digital technologies to support the cervical cancer elimination efforts that are underway in many countries around the world. At the 35th International Papillomavirus Conference (IPVC) in April 2023, Dr Luis Riba of Roche Diagnostics described how digital solutions can account for key challenges in cervical cancer […]

Co-creating digital solutions to support cervical cancer screening Read More »

Implementing p16/ki67 dual stain at a large US commercial lab: Dr Tamera Paczos

Implementing p16/ki67 dual stain at a large US commercial lab: Dr Tamera Paczos

As Vice President and Associate Chief Medical Officer at BioReference Laboratories, one of the largest clinical labs in the United States, Dr Tamera Paczos oversaw the addition of p16/Ki-67 dual staining assays to the lab’s assay portfolio. In the US, these assays are used in triage to further risk stratify women who have come for

Implementing p16/ki67 dual stain at a large US commercial lab: Dr Tamera Paczos Read More »

Prof Mark Stoler on HPV primary screening with biomarker based triage

Prof Mark Stoler on HPV primary screening with biomarker based triage_thumbnail

While cervical cancer is preventable, an estimated 14,000 new cases are diagnosed in the United States every year, leading to almost 4,300 deaths from the disease. As Professor Emeritus of Pathology and Clinical Gynaecology at the University of Virginia Health System, Prof Mark Stoler is working towards preventing these deaths.  In this talk at the

Prof Mark Stoler on HPV primary screening with biomarker based triage Read More »

How labs can help to reduce the burden of STIs and infertility

How labs can help to reduce the burden of STIs and infertility

When it comes to women’s health, levels of knowledge and awareness of sexual and reproductive health vary in Asia Pacific. Diverse beliefs and cultures often lead to stigmatisation around Sexually Transmitted Infections (STIs). STIs like Chlamydia trachomatis (CT or Chlamydia) and Neisseria gonorrhoeae (GC or gonorrhoeae) can negatively impact the health of women causing a

How labs can help to reduce the burden of STIs and infertility Read More »

VTE associated with hormone therapy and pregnancy: Assoc Prof Lai Heng Lee on risk and management

VTE associated with hormone therapy and pregnancy - Assoc Prof Lai Heng Lee on risk and management_thumbnail

At the annual Roche Diagnostics-sponsored event pro-COAG event (2022), Prof Lai Heng Lee gave an insightful presentation on the risk management of venous thromboembolism (VTE) associated with hormone therapy and pregnancy. Below are some key takeaways. Hormone-associated venous thromboembolism (VTE) The incidence of VTE in young women is generally 1/10,000 per year. However, hormonal therapy

VTE associated with hormone therapy and pregnancy: Assoc Prof Lai Heng Lee on risk and management Read More »

Venous thromboembolism (VTE) in women: incidence, risk factors and treatment

Venous thromboembolism (VTE) in women: incidence, risk factors and treatment

Venous thromboembolism (VTE) refers to blood clots that develop in the veins [1]. The two most common manifestations of VTE are deep vein thrombosis (DVT) and pulmonary embolism (PE) [1]. DVT is when a blood clot develops in a deep vein, and PE occurs when a clot breaks loose, travels through the bloodstream, and lodges

Venous thromboembolism (VTE) in women: incidence, risk factors and treatment Read More »

Advancing women’s health: optimising cervical cancer screening in Thailand

Advancing women’s health: optimising cervical cancer screening in Thailand

Since 2020, Thailand has used HPV DNA tests as a way to optimise primary screening programmes for cervical cancer. The country conducted internal studies on the cost-effectiveness of HPV tests within primary screening and found it economical. To increase coverage amongst the unscreened or under-screened population, self-sampling was introduced to address cultural and/or religious barriers

Advancing women’s health: optimising cervical cancer screening in Thailand Read More »

Advancing women’s health: HPV screening methods in Singapore

Advancing women’s health: HPV screening methods in Singapore

HPV screening programmes are being rolled out across many countries in a bid to eliminate cervical cancer by 2030, a target that has been set out by the World Health Organisation. As more countries gain access to innovative technology and greater experience in cervical cancer screening, some are exploring updating screening algorithms in order to

Advancing women’s health: HPV screening methods in Singapore Read More »

Advancing women’s health: key takeaways from AOGIN 2022

Advancing women’s health: key takeaways from AOGIN 2022

With face-to-face conferences and scientific symposiums back on, the Lab Insights team recently attended the 14th meeting of the Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN 2022). Distinguished speakers from around the world gathered to talk about human papillomavirus (HPV) and the several cancers it can cause, the most notable among them being

Advancing women’s health: key takeaways from AOGIN 2022 Read More »

Scroll to Top